Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A detailed look at Seer’s Q1 2026 earnings, the forces shaping growth, and practical moves investors can make now. Le...
A new Harvard study shows the income needed to afford median-priced homes has nearly doubled since 2020, highlighting...
In 2025, Marathon Petroleum delivered a powerful cash-return story for shareholders. This article breaks down how the...
Wix faced a sharp stock drop after its quarterly results and cautious analyst notes. This article breaks down the fac...
Millions overlook their 401(K) match, costing households nearly $3,000 annually. The trend threatens long-term retire...
'trump accounts' earn your kids a potential $270,000 by age 18, depending on market performance and registered contri...
Investors eye the long end of the curve as Kevin Warsh's QT stance shifts income dynamics. Forget utility dividends. ...
A new Fed chair can ripple through markets, but panic isn’t the right play. This article breaks down why chairman kev...
A high-flying AI infrastructure stock surged 176% in a single year. This guide breaks down what powered that move, wh...
A 67-year-old single retiree with $920,000 could extend retirement beyond typical horizons if Social Security COLA re...
As coastal Florida draws more retirees, a 62-year-old with $1.3 million weighs whether the Boca Raton lifestyle can l...